NCT06483425进行中（未招募）不适用
A Biomarker Exploration Study of Precision Treatment in Ovarian Cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 2,000
- 试验地点
- 1
- 主要终点
- Biomarker explorarion
研究概览
简要总结
This clinical trial aims to investigate the role of biomarkers in guiding precision treatment for ovarian cancer. The study will explore the effectiveness of personalized treatment strategies based on specific biomarkers identified in ovarian cancer patients. By analyzing the correlation between biomarker profiles and treatment outcomes, the trial seeks to optimize treatment decisions and improve overall survival rates in ovarian cancer patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Patients diagnosed with ovarian cancer.
- •Willingness to undergo biomarker testing.
- •Ability to provide informed consent for participation in the study.
排除标准
- •Inability to comply with study requirements or follow-up visits.
- •Previous participation in a conflicting clinical trial.
结局指标
主要结局
Biomarker explorarion
时间窗: 5 years
Blood, tumor, and other samples should be sequenced by RNA-seq, Next-Generation Sequencing, or proteomics to identify specific biomarkers associated with treatment response and prognosis in ovarian cancer.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
撤回
不适用
ovel therapeutic targets and biomarkers in patients with Systemic Lupus Erythematosussystemic lupus erythematosusSLE10003816NL-OMON35524niversitair Medisch Centrum Utrecht62
终止
不适用
Guiding Evidence Based Therapy Using Biomarker Intensified TreatmentHeart FailureNCT01685840Duke University894
尚未招募
不适用
Biomarkers in Predicting Treatment Response in Samples From Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant ChemotherapyStage IA Non-small Cell Lung CancerStage IB Non-small Cell Lung CancerStage IIA Non-small Cell Lung CancerStage IIB Non-small Cell Lung CancerStage IIIA Non-small Cell Lung CancerNCT01595074National Cancer Institute (NCI)950
进行中（未招募）
不适用
An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal CancerColorectal CancerNCT02394834Takeda757
终止
1 期
Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Extracellular Vesicles (EVs), Patient-derived Organoid (PDOs)s and Immune-marker Positron Emission Tomography (PET) Scanning in Non-small Cell Lung Cancer (NSCLC)Lung Cancer, Non-Small CellNCT06405230GlaxoSmithKline2